» Articles » PMID: 19266498

The Pro-Th2 Cytokine IL-33 Directly Interacts with Invariant NKT and NK Cells to Induce IFN-gamma Production

Overview
Journal Eur J Immunol
Date 2009 Mar 7
PMID 19266498
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

IL-33 has recently been identified as a cytokine endowed with pro-Th2 functions, raising the question of its effect on invariant natural killer T cell (iNKT), which are potent IL-4 producers. Here, we report a two-fold increase of iNKT-cell counts in spleen and liver after a 7-day treatment of mice with IL-33, which results from a direct effect, given that purified iNKT cells express the T1/ST2 receptor constitutively and respond to IL-33 by in vitro expansion and functional activation. Conversely to the expected pro-Th2 effect, IL-33 induced a preferential increase in IFN-gamma rather than IL-4 production upon TCR engagement that depended on endogenous IL-12. Moreover, in combination with the pro-inflammatory cytokine IL-12, IL-33 enhanced IFN-gamma production by both iNKT and NK cells. Taken together these data support the conclusion that IL-33 can contribute as a co-stimulatory factor to innate cellular immune responses.

Citing Articles

invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


Deciphering the circulating immunological landscape of thoracic aortic aneurysm: Insights from a two-sample Mendelian randomization study.

Gao H, Wang X, Gan H, Li M, Shi J, Guo Y Heliyon. 2024; 10(10):e31198.

PMID: 38803862 PMC: 11128510. DOI: 10.1016/j.heliyon.2024.e31198.


Dysbiosis of Gut Microbiome Aggravated Male Infertility in Captivity of Plateau Pika.

Zhang L, Tang X, Fan C, Ren S, Cheng Q, Zhou H Biomolecules. 2024; 14(4).

PMID: 38672421 PMC: 11047922. DOI: 10.3390/biom14040403.


Innate Type-2 Cytokines: From Immune Regulation to Therapeutic Targets.

Kim H, Jeong D, Kim J, Chung D Immune Netw. 2024; 24(1):e6.

PMID: 38455467 PMC: 10917574. DOI: 10.4110/in.2024.24.e6.


IL-33-binding HpARI family homologues with divergent effects in suppressing or enhancing type 2 immune responses.

Colomb F, Ogunkanbi A, Jamwal A, Dong B, Maizels R, Finney C Infect Immun. 2024; 92(3):e0039523.

PMID: 38294241 PMC: 10929406. DOI: 10.1128/iai.00395-23.